Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    

Oct. 13: Vanderbilt University Medical Center Hosts Bone Marrow Disorders Symposium


Vanderbilt University Medical Center (VUMC) clinicians will host an educational symposium on bone marrow disorders, including bone marrow failure, acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The free symposium for health care practitioners, sponsored by VUMC and the Aplastic Anemia and MDS International Foundation, will be held Friday, Oct. 13, 11:30 a.m. - 6 p.m., at the Omni Nashville Hotel, 250 5th Ave. South.

Bone marrow disease specialists from VUMC and other leading medical centers will provide the latest information on the diagnosis and management of bone marrow failure and myeloid malignancies based on current clinical practice guidelines and recent research studies. The expert faculty will provide insight into these rare disorders and offer recommendations for clinical practice.

Course director Michael Savona, M.D., associate professor of Medicine and director of Hematology Research at VUMC notes, "This is a unique opportunity for our local and referring medical communities to hear about exciting new drug approvals and treatment considerations specifically for myeloid cancers and bone marrow failure."

The educational sessions are appropriate for health care professionals working with patients with leukemia, MDS and other bone marrow failure, including hematologists, advance practice providers, oncologists, primary care physicians, pediatricians, pathologists, residents/fellows, physician assistants, nurses and nurse practitioners, and pharmacists. The activity is approved for continuing medical education (CME) credits.

VUMC faculty include Stephen Strickland Jr., M.D., M.S.C.I., assistant professor of Medicine and clinical director of Acute Leukemia, who will discuss newly approved therapy for AML; Michael Byrne, D.O., assistant professor of Medicine, who will review post-hematopoietic stem cell transplant relapse in AML; and Tamara Moyo, M.D., Ph.D., instructor of Medicine, who will discuss bone marrow failure and the role of stem cell transplant in patients with bone marrow failure.

They will be joined by Daniel Pollyea, M.D., M.S., clinical director of Leukemia Services at the University of Colorado School of Medicine, who will highlight new therapies including BCL-2 inhibitors; Mrinal Patnaik, M.B.B.S., assistant professor of Medicine at the Mayo Clinic, who will review strategies for overlaps syndromes (such as CMML) that have properties of both MDS and myeloproliferative neoplasms; and Amy DeZern, M.D., M.H.S., assistant professor of Medicine at Johns Hopkins School of Medicine, who will discuss the different types of myelodysplastic syndromes.

To register for the event, visit or contact for more information.


Related Articles:

Recent Articles

The Promise of Blockchain

Change Healthcare's Aaron Symanski says there are a lot of questions around blockchain ... and that's a good thing because it means there are many uses for the transformational technology in healthcare.

Read More

Change Healthcare Launches First Blockchain Solution

On Sept. 25, Change Healthcare announced the launch of the first blockchain solution for enterprise-scale use in healthcare, enabling payers and providers to boost revenue cycle efficiency, improve real-time analytics, cut costs, and create innovative new services.

Read More

NMGMA: 10 Minute Takeaway

The one constant is change - MGMA Associate Director of Government Affairs recently briefed practice managers on the latest from Washington, D.C.

Read More

M&A Trends & Technology

Even in an uncertain landscape, healthcare deals are getting done ... but buyers and sellers are becoming more discriminate.

Read More

THA Launches Data Sharing Initiative for TennCare Patients

New data sharing software is expected to improve communication, decrease emergency visits for TennCare patients

Read More

TOA Update

The state's largest orthopaedic surgery group continues to expand its offerings.

Read More

Innovation in Orthopaedics

Lorio's living hinge cages expected to change the future of spinal surgery.

Read More

The M&A Perspective

There's more to joining forces than signing on the dotted line. Jeff Seraphine, LifePoint Health's M&A chief, shares his insights on making what looks good on paper work in practice, as well.

Read More

The Little Clinic: Retail Health in the Continuum of Care

A rise in healthcare consumerism, patient demand for convenience and pricing clarity, and a looming provider shortage in some markets have helped fuel the growth of The Little Clinic and other retail health providers.

Read More

Novel Knee Surgery Uses Patient's Regrown Cartilage Cells

Vanderbilt has become the first in Tennessee to perform next gen knee surgery with an implant containing the patient's own regrown cartilage cells.

Read More

Email Print



Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: